|
57
|
204
|
5l66I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
62
|
231
|
5lajE |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
66
|
216
|
5lf6M |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
68
|
240
|
5l5uC |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
69
|
244
|
5l62B |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
250
|
5l65A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
62
|
220
|
5lf4H |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
69
|
250
|
5l5rA |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
56
|
195
|
5l5yJ |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
255
|
652
|
4z40A |
Active site complex bambc of benzoyl coenzyme a reductase as isolated |
|
68
|
242
|
5laiD |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
220
|
5leyH |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
68
|
242
|
5l5bD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
63
|
241
|
5l5dG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
195
|
5l66J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
211
|
5l63K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
71
|
244
|
5l5wB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
59
|
196
|
5lajN |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
68
|
213
|
5le5L |
Native human 20s proteasome at 1.8 angstrom |
|
67
|
250
|
5l54A |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
70
|
244
|
5l5sB |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
58
|
195
|
5l61J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
58
|
196
|
5l69N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
71
|
243
|
5laiF |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
65
|
200
|
5lf6K |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
59
|
195
|
5l5rJ |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
70
|
243
|
5l6cF |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
73
|
248
|
5lf0B |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
60
|
222
|
5l5pL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
58
|
204
|
5l60I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
61
|
230
|
5lf0A |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
68
|
240
|
5lttC |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
62
|
211
|
5l5jK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
67
|
244
|
5laiB |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
69
|
240
|
5l66C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
65
|
244
|
5lf3G |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
67
|
250
|
5l55A |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
69
|
242
|
5l5tD |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
71
|
243
|
5l63F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
222
|
5l5rL |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
64
|
241
|
5l5rG |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
61
|
222
|
5laiL |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
60
|
196
|
5l5yN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
68
|
211
|
5laiK |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
70
|
239
|
5lezF |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
64
|
211
|
5m2bK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
69
|
244
|
5l5eB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
60
|
222
|
5l5zL |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
226
|
5lajH |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
100
|
308
|
4z5yA |
The 1.56-angstrom crystal structure of copper(ii)-bound pqqb from pseudomonas putida |
